Discover 2,355 paid clinical trials in Joliet, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,355
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Location: Chicago IL, Iowa City IA, St Louis MO, Columbus OH,
Sponsor: Syndax Pharmaceuticals
Sex: All
Age: 0+
Code: NCT04065399
Phase1, Phase2, Recruiting
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
for
Solid Tumor, Adult, Mesothelioma, NSCLC
Location: Chicago IL, Minneapolis MN, Arlington VA, New York NY,
Sponsor: Vivace Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT04665206
Phase1, Phase2, Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
for
Prostate Cancer,
Location: Chicago IL, Milwaukee WI, Madison WI, St Louis MO,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18 - 70+
Code: NCT05519449
Phase1, Recruiting
Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
for
Relapsed Classic Hodgkin Lymphoma
Location: Chicago IL, Nashville TN, Hackensack NJ, Boston MA,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT04561206
Phase2, Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Chicago IL, Madison WI, Iowa City IA, Rochester MN,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Chicago IL, Rochester MN, Columbus OH, Fairfax VA,
Sponsor: 858 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06395519
Phase1, Phase2, Recruiting
Olaparib in Patients With HRD Malignant Mesothelioma
for
Mesothelioma, Homologous Recombination Deficiency
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT04515836
Phase2, Recruiting
Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
for
Mechanical Ventilation Complication
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT03901924
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
for
Primary Biliary Cholangitis
Location: Chicago IL, Iowa City IA, Louisville KY, Detroit MI,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06051617
Phase3, Recruiting
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
for
Advanced Solid Tumors Cancer, MSI-H Cancer
Location: Chicago IL, Maumee OH, Louisville KY, Toronto,
Sponsor: Nimbus Wadjet, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06898450
Phase1, Phase2, Recruiting
Dex +/- Caffeine Sedation in a Post-MRI Recovery in a Pediatric Population
for
Enhanced Recovery After Surgery in a Pediatric Population
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 3 - 12
Code: NCT06538584
Phase1, Phase2, Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant